Former US President Joe Biden Diagnosed with Aggressive Prostate Cancer

Strategic Insights -

Former US President Joe Biden, 82, has been diagnosed with an aggressive form of prostate cancer that has spread to his bones, according to his office. The cancer is classified as "high-grade" with a Gleason score of 9 out of 10, meaning it can spread quickly. Biden and his family are reviewing treatment options, and the cancer is hormone-sensitive, making it manageable. Biden's health issues have sparked support from both sides of the aisle, with President Donald Trump and former Vice-President Kamala Harris offering their well-wishes.

Key Takeaways:

  • Biden's cancer is classified as "high-grade" with a Gleason score of 9 out of 10, indicating aggressive and potentially deadly nature.
  • The cancer has spread to his bones, which is typically considered incurable, although treatment can manage symptoms and slow cancer growth.
  • Biden's cancer is hormone-sensitive, making it potentially manageable with hormonal therapies.
  • The former president has been treated with urinary symptoms for several years and had largely retreated from public life.
  • Biden has a long history of advocating for cancer research and launched the Cancer Moonshot initiative with his wife in 2022.
  • His health issues have sparked nationwide concern and debate about age and health limitations on public office.

Statistics:

  • 13 out of every 100 men will develop prostate cancer at some point in their lives, according to the US Centers for Disease Control and Prevention (CDC).
  • Prostate cancer is the second most common cancer affecting men, behind skin cancer, according to the Cleveland Clinic.
  • Biden's cancer has a Gleason score of 9 out of 10, indicating a high risk of cancer spreading quickly.
  • Hormonal therapies are likely to be used to manage symptoms and slow cancer growth, as suggested by Dr. William Dahut of the American Cancer Society.

Sources:

  • A statement from Joe Biden's office dated Sunday
  • Information from Cancer Research UK
  • An interview with Dr. William Dahut on the BBC
  • An article from the Cleveland Clinic
  • The US Centers for Disease Control and Prevention (CDC) report